投稿信息
投稿信息
审稿周期
投稿命中率
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
4.1 %
年文章数
1177
作者需知
暂无数据
NCBI查询
期刊简介
稿件收录要求
稿件收录要求
Published by Elsevier Science.
ISSN: 1472-9792.
The resurgence of interest in tuberculosis (TB) has accelerated the pace of TB research. Tuberculosis has been reoriented to allow focus on basic research advances, particularly those with relevance to TB control and eventual elimination. An outstanding international Editorial Board has been assembled and welcomes contributions in the areas of immunology,immunogenetics, pathogenetics, microbiology, microbial physiology, pathogenesis, pathology, molecular epidemiology, diagnostic, vaccine development, drug development and drug resistance. Our intent is that Tuberculosis will publish outstanding peer-reviewed biomedical research relevant to tuberculosis.
The resurgence of interest in tuberculosis (TB) has accelerated the pace of TB research. Tuberculosis has been reoriented to allow focus on basic research advances, particularly those with relevance to TB control and eventual elimination. An outstanding international Editorial Board has been assembled and welcomes contributions in the areas of immunology,immunogenetics, pathogenetics, microbiology, microbial physiology, pathogenesis, pathology, molecular epidemiology, diagnostic, vaccine development, drug development and drug resistance. Our intent is that Tuberculosis will publish outstanding peer-reviewed biomedical research relevant to tuberculosis.
